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httpIntroduction: Hand ischemia following vascular access surgery is an uncommon complication. A clinical dilemma
exists between prioritizing the preservation of vascular access and the need for surgical intervention to rescue
the ischemic hand.
Report: An 80 year old man who had hand ischemia following creation of a polytetraﬂuoroethylene
arteriovenous graft with clinical evidence of ischemic pain of the left hand and Doppler ultrasound evidence of
diastolic ﬂow reversal is described. Far infrared therapy (FIR) was applied over the distal part of the affected limb,
and the symptoms and signs of ischemia improved remarkably. Follow up ultrasonography also revealed the
disappearance of diastolic ﬂow reversal.
Discussion: FIR therapy is a promising and non-invasive therapeutic modality to treat vascular access related
hand ischemia by decreasing vascular resistance and improving hand perfusion
 2015 The Authors. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Hand ischemia after creation of an arteriovenous graft
(AVG) is a less common complication than thrombosis or
infection. However, it is a more challenging complication
because it poses the clinical dilemma of whether to prior-
itize preservation of the patient’s vascular access or reso-
lution of the distal ischemia. Various strategies have been
developed to solve this problem, including ligation, partial
banding of the access conduit, or a new anastomosis. Here,
a case of hand ischemia shortly after establishment of AVG,
successfully treated by far infrared (FIR) therapy, is
reported.CASE REPORT
An 80 year old man with type 2 diabetes mellitus, hyper-
tension, and end stage renal disease due to diabetic kidney
disease was admitted for creation of vascular access.rresponding author. School of Medicine, National Yang-Ming
sity, Taipei, Taiwan, ROC.
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://dx.doi.org/10.1016/j.ejvssr.2015.08.004Implantation of a polytetraﬂuoroethylene AVG was per-
formed in the left upper arm. Unfortunately, the patient
began to suffer from progressive numbness, swelling, and
coldness of the left upper extremity distal to the arterial
graft anastomotic site in the ﬁrst few days after surgery.
Doppler ultrasonography of the left upper extremity
revealed a high graft ﬂow of 1,900 mL/min. Steal phe-
nomenon with diastolic ﬂow reversal (“to and fro” ﬂow
pattern) at the left radial artery was also noted. Peak sys-
tolic velocity was 20.0 cm/second with a reverse diastolic
velocity of 9.6 cm/second, leading to a resistive index (RI) of
1.48 (Fig. 1), suggestive of hand ischemia induced by the
AVG. Far infrared therapy was applied, mainly from the left
palm to the distal half of the left forearm (Fig. 2). The
duration of far infrared therapy was 40 minutes per session,
with a frequency of three times daily. The numbness and
swelling of the forearm and palm subsided within a few
days, and follow up Doppler ultrasonography showed
decreased reversal of the diastolic ﬂow at the left radial
artery after FIR therapy 4 months later. Spectral Doppler
demonstrated an increasing peak systolic velocity of 41.9
cm/second (signiﬁcantly higher than 20.0 cm/second before
treatment) and a reversed diastolic velocity of 7.4 cm/sec-
ond, with an RI of 1.18 (Fig. 3). There was also an increase
of digital pressure from 69 to 78 mmHg and digital brachial
Figure 1. Steal phenomenon with diastolic ﬂow reversal is noted at the left radial artery. The peak systolic velocity is 20.0 cm/s and diastolic
velocity is 9.6 cm/s, with a resistive index (RI) of 1.48.
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cating the improvement of hand ischemia.DISCUSSION
Hand ischemia following the establishment of vascular ac-
cess, referred to as dialysis access associated steal syndrome
or access related hand ischemia, makes up only approxi-
mately 1.6e8.0% of complications in patent vascular access.1
Major predisposing risk factors include use of the brachial
artery for inﬂow, diabetes, female sex, and age >60 years.1
Surgical intervention is almost inevitable for patients with
severe access related hand ischemia. Flow limiting pro-
cedures, including banding, anastomosis reduction, outﬂow
reduction, or even access ligation, solve the distal hand
ischemia but also compromise the vascular access ﬂow. TheFigure 2. Far infrared therapy was applied to the distal part of the
patient’s left upper limb to increase regional circulation and to
alleviate the steal syndrome.distal revascularization interval ligation procedure is
currently one of most widely used revascularization oper-
ations to restore distal limb blood ﬂow. Recently, revision
using distal inﬂow and proximalization of the arterial inﬂow
are proposed as promising solutions.2
FIR therapy is a promising treatment for the prevention
of vascular access malfunction. In a previous randomized,
controlled trial on the therapeutic effect of FIR therapy on
arteriovenous ﬁstula (AVF) patency in 145 stable hemodi-
alysis patients at a single tertiary medical center, incre-
mental changes in blood ﬂow were signiﬁcantly higher in
the single HD session with FIR than in that without FIR. FIR
was also associated with a lower incidence of AVF mal-
function (12.5 vs. 30.1%; p < .01) and a higher primary
unassisted patency (85.9 vs. 67.6%; p < .01) after the 1 year
follow up.3
Another open labelled randomized trial on 122 patients
with a newly constructed AVF proved that patients who
received FIR therapy had a higher rate of physiological AVF
maturation (90% vs. 76%) at 3 months, a lower rate of AVF
malfunction, and higher rates of cumulative unassisted
patency and clinical maturation (82% vs. 60%) within 12
months.4 Furthermore, 5 year follow up demonstrated
uremic patients who simultaneously received FIR therapy
during hemodialysis had a signiﬁcantly higher cumulative
AVF patency (87.1% vs. 78.7% for controls).5 Genomic
analysis demonstrated that the beneﬁcial effects were
possibly mediated through heme oxygenase-1.5
FIR therapy possesses the thermal effect of vasodilatation
and multiple non-thermal effects, such as augmentation of
endothelial nitric oxide synthase (eNOS) expression.6 Neo-
intimal hyperplasia, one of the most important mechanisms
of stenosis in vascular access, is also inhibited by FIR
Figure 3. Decreased reversal of the diastolic ﬂow in the left radial artery after far infrared therapy. Spectral Doppler demonstrates a peak
systolic velocity of 41.9 cm/s (signiﬁcantly increased compared with before treatment) and diastolic velocity of 7.4 cm/s, with a resistive
index of 1.18.
32 Y.-W. Chen et al.therapy.7 In addition, patients who received FIR dry sauna
for 45 minutes daily for 2 weeks had lower levels of urinary
8-epi-prostaglandin F2a, which is a reliable marker of
oxidative stress for lipid peroxidation in vivo.8
FIR also has an anti-inﬂammatory effect, shown in a
previous in vitro study. First, it stimulated expression of
anti-inﬂammatory HO-1 in human umbilical vein endothelial
cells (HUVECs). Second, FIR inhibited tumor necrosis factor-
a mediated expression of endothelial adhesion molecules,
as well as the production of pro-inﬂammatory cytokines and
chemokines.9
Recently, another in vitro study also showed that FIR
therapy can successfully suppress epidermal growth factor
(VEGF) induced proliferation of HUVECs by phosphorylation
of eNOS, inhibition of VEGF induced phosphorylation of
extracellular signal regulated kinases, and nuclear trans-
location of promyelocytic leukemia zinc ﬁnger protein.10
In this case, FIR therapy has been shown to improve
microcirculation and decrease the vascular resistance over
the arterial system distal to the graft anastomosis, including
the distal radial artery and the arterial arches of the palm,
leading to a signiﬁcant restoration of the diastolic reverse
ﬂow at the left radial artery. To the best of the authors’
knowledge, this is the ﬁrst report of the use of FIR therapy
to increase the microcirculation of the distal part of the
ischemic extremity. In conclusion, FIR therapy may be a
novel and promising non-invasive therapeutic modality to
relieve AVG related hand ischemia.CONFLICT OF INTEREST
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